Search research articles
Contact Us
Filters
Showing results (11-20 of 37) with videos related to
Page
of 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 29, 2020
Effect of Dexrazoxane on Left Ventricular Systolic Function and Treatment Outcomes in Patients With Acute Myeloid Leukemia: A Report From the Children's Oncology Group
Kelly D Getz, Lillian Sung, Todd A Alonzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 9, 2015
Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group
Katherine Tarlock, Todd A Alonzo, Robert B Gerbing, et al.
Blood
|
March 2, 2012
Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML
Jessica A Pollard, Todd A Alonzo, Michael Loken, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 6, 2025
Germline Variant Burden Warrants Universal Genetic Testing in Pediatric Myeloid Leukemia
Lauren M Harmon, Zachary S Hattig, Yizhou Peter Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2021
Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric <i>KMT2A</i>-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531
Jessica A Pollard, Erin Guest, Todd A Alonzo, et al.
Transplantation and Cellular Therapy
|
June 18, 2022
Hematopoietic Cell Transplantation in the Treatment of Pediatric Acute Myelogenous Leukemia and Myelodysplastic Syndromes: Guidelines from the American Society of Transplantation and Cellular Therapy
Katherine Tarlock, Maria Luisa Sulis, Joseph H Chewning, et al.
Blood
|
April 24, 2010
Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group
Phoenix A Ho, Rong Zeng, Todd A Alonzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 30, 2010
WT1 synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-risk pediatric acute myeloid leukemia: a report from the children's oncology group
Phoenix A Ho, Julia Kuhn, Robert B Gerbing, et al.
Pediatric Blood & Cancer
|
February 10, 2015
Sorafenib treatment following hematopoietic stem cell transplant in pediatric FLT3/ITD acute myeloid leukemia
Katherine Tarlock, Bill Chang, Todd Cooper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 24, 2017
CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531
Jatinder K Lamba, Lata Chauhan, Miyoung Shin, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 37) with videos related to
Sort By:
Page
of 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 29, 2020
Effect of Dexrazoxane on Left Ventricular Systolic Function and Treatment Outcomes in Patients With Acute Myeloid Leukemia: A Report From the Children's Oncology Group
Kelly D Getz, Lillian Sung, Todd A Alonzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 9, 2015
Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group
Katherine Tarlock, Todd A Alonzo, Robert B Gerbing, et al.
Blood
|
March 2, 2012
Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML
Jessica A Pollard, Todd A Alonzo, Michael Loken, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 6, 2025
Germline Variant Burden Warrants Universal Genetic Testing in Pediatric Myeloid Leukemia
Lauren M Harmon, Zachary S Hattig, Yizhou Peter Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2021
Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric <i>KMT2A</i>-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531
Jessica A Pollard, Erin Guest, Todd A Alonzo, et al.
Transplantation and Cellular Therapy
|
June 18, 2022
Hematopoietic Cell Transplantation in the Treatment of Pediatric Acute Myelogenous Leukemia and Myelodysplastic Syndromes: Guidelines from the American Society of Transplantation and Cellular Therapy
Katherine Tarlock, Maria Luisa Sulis, Joseph H Chewning, et al.
Blood
|
April 24, 2010
Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group
Phoenix A Ho, Rong Zeng, Todd A Alonzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 30, 2010
WT1 synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-risk pediatric acute myeloid leukemia: a report from the children's oncology group
Phoenix A Ho, Julia Kuhn, Robert B Gerbing, et al.
Pediatric Blood & Cancer
|
February 10, 2015
Sorafenib treatment following hematopoietic stem cell transplant in pediatric FLT3/ITD acute myeloid leukemia
Katherine Tarlock, Bill Chang, Todd Cooper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 24, 2017
CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531
Jatinder K Lamba, Lata Chauhan, Miyoung Shin, et al.
Page
of 4